当前位置: 首页 > 期刊 > 《中国保健营养》 > 2013年第2期 > 正文
编号:12361487
B型脑钠肽前体在肺心病合并冠心病中的临床意义(2)
http://www.100md.com 2013年1月15日 范晓艳 郭瑞斌
    参见附件(12kb)。

     参考文献

    [1]Studler U,KretzschmarM,ChristM,et a.l Accuracy of chest rad-iographs in the emergen cyd iagnosis of heart failure.Eur Radio,2008,18(8):1644-1652.

    [2]Hunt PJ,Richards AM ,Nicholls MG,et al.Immunoreactive aminoterminal pro-brain nat riuretic peptide (NT-PROBNP):a new marker of cardi ac impairment.Clin Endocrinol,1997,47:287

    [3]王晓平,柯会星,王厚东,等.46例老年肺心病病理与临床对比分析[J].中华结核和呼吸系疾病杂志,1997,20(4):288.

    [4]张乐平,徐永乐.113例老年慢性肺心病临床分析[J].临床肺科杂志,2006,7(3):19.

    [5]FuatA,Murphy JJ,Hungin AP,et a.l The diagnostic accuracy andutility of a B-type natriuretic p eptide test in a community population of patients with suspected heart failure.BrJGen Pract,2006,56(526):327-333.

    [6]McK ie PM,Burnett JC Jr.B-type natriuretic peptide as a biomarker beyond heart failure:specu lations and opportunities.Mayo ClinProc,2005,80(8):1029-1036.

    [7]Dhaliwal AS,Deswal A,Pritchett A,et al.Reduction in BNP levels with treatment of decompensated heart failure and future clinical events[J].J Card Fail,2009,15(4):293-299.

    [8]Bettencourt P,Frioes F,Azevedo A,et al.Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure[J].Int J Cardiol,2004,93(1):45-48.

您现在查看是摘要介绍页,详见PDF附件(12kb)